Beiboer Sigrid H W, Wieringa-Jelsma Tinka, Maaskant-Van Wijk Petra A, van der Schoot C Ellen, van Zwieten Rob, Roos Dirk, den Dunnen Johan T, de Haas Masja
Sanquin Research at CLB and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Transfusion. 2005 May;45(5):667-79. doi: 10.1111/j.1537-2995.2005.04319.x.
In the Netherlands, 500,000 blood donors are active. Blood of all donors is currently typed serologically for ABO, the Rh phenotype, and K. Only a subset of donors is typed twice for a larger set of red cell (RBC) and/or platelet (PLT) antigens. To increase the direct availability of typed RBCs and PLTs, a high-throughput technique is being developed to genotype the whole donor cohort for all clinically relevant RBC and PLT antigens.
A multiplex polymerase chain reaction was developed to both amplify and fluorescently label 19 gene fragments of RBC and PLT antigens in one reaction. To test the setup of the genotyping method by microarray, a pilot study with human PLT antigen (HPA)-typed donor samples was performed. On each slide, 12 arrays are present containing 20 probes per PLT antigen system (28 for HPA-3). The allele-specific oligohybridization method was used to discriminate between two different alleles.
Two blinded panels encompassing 94 donors were genotyped for HPA-1 through -5 and -15; no discrepancies were found compared to their serologic typing (HPA-1, -2, -3, -4, and -5) and genotyping (HPA-15; TaqMan, Applied Biosystems).
This study shows that the HPA microarray provides a reliable and fast genotyping procedure. With further development an automated throughput for complete typing of large donor cohorts can be obtained.
在荷兰,有50万名活跃的献血者。目前,所有献血者的血液都通过血清学方法进行ABO血型、Rh表型和K抗原分型。只有一部分献血者针对更多种类的红细胞(RBC)和/或血小板(PLT)抗原进行了两次分型。为了提高分型后的RBC和PLT的直接可用性,正在开发一种高通量技术,用于对所有临床相关的RBC和PLT抗原对整个献血者队列进行基因分型。
开发了一种多重聚合酶链反应,可在一次反应中扩增并荧光标记RBC和PLT抗原的19个基因片段。为了通过微阵列测试基因分型方法的设置,对人类血小板抗原(HPA)分型的献血者样本进行了一项试点研究。每张载玻片上有12个阵列,每个PLT抗原系统包含20个探针(HPA-3为28个)。采用等位基因特异性寡杂交方法区分两种不同的等位基因。
对包含94名献血者的两个盲法样本组进行了HPA-1至-5和-15的基因分型;与他们的血清学分型(HPA-1、-2、-3、-4和-5)和基因分型(HPA-15;应用生物系统公司的TaqMan法)相比,未发现差异。
本研究表明,HPA微阵列提供了一种可靠且快速的基因分型程序。随着进一步发展,可以实现对大量献血者队列进行完整分型的自动化通量。